Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Page 1
Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
Xiao M, Zhong LLD, Lam WC, Zhao Y, Gwee KA, Holtmann G, Tack J, Suzuki H, Chen MH, Xiao Y, Hou X, Liu J, Li Y, Tang XD, Lu F. Xiao M, et al. Among authors: gwee ka. Trials. 2022 Jun 2;23(1):454. doi: 10.1186/s13063-022-06396-5. Trials. 2022. PMID: 35655286 Free PMC article.
Compared to the previous clinical trial that targeted FD-PDS, this trial will have an 8-week double-blind treatment period to investigate the effect of long-term mediation through comparison with the placebo group. TRIAL REGISTRATION: ClinicalTrials.gov NCT03825692 . ...
Compared to the previous clinical trial that targeted FD-PDS, this trial will have an 8-week double-blind treatment period to investigate th …
"It ain't over … till it's over!" Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic.
Holtmann G, Quigley EM, Shah A, Camilleri M, Tan VP, Gwee KA, Sugano K, Sollano JD, Fock KM, Ghoshal UC, Chen M, Dignass A, Cohen H. Holtmann G, et al. Among authors: gwee ka. J Gastroenterol Hepatol. 2020 Jul;35(7):1117-1123. doi: 10.1111/jgh.15133. Epub 2020 Jun 29. J Gastroenterol Hepatol. 2020. PMID: 32511791 Free PMC article. Review.
Local health systems aim to contain the COVID-19 pandemic and hospitals and health-care providers rush to provide the capacity for a surge of COVID-19 patients. However, the short, medium-term, and long-term outcomes of patients with gastrointestinal (GI) diseases w …
Local health systems aim to contain the COVID-19 pandemic and hospitals and health-care providers rush to provide the capacity for a surge o …
Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice.
Ho KY, Gwee KA, Cheng YK, Yoon KH, Hee HT, Omar AR. Ho KY, et al. Among authors: gwee ka. J Pain Res. 2018 Sep 20;11:1937-1948. doi: 10.2147/JPR.S168188. eCollection 2018. J Pain Res. 2018. PMID: 30288088 Free PMC article. Review.
Celecoxib has a better lower-GI-tract tolerability profile than ns-NSAIDs plus a proton-pump inhibitor. In addition, the latest data suggest that long-term use of celecoxib 200 mg/day may be appropriate for patients at increased CV risk....
Celecoxib has a better lower-GI-tract tolerability profile than ns-NSAIDs plus a proton-pump inhibitor. In addition, the latest data suggest …